AACC 2016: DRG International to exhibit Optimized Saliva ELISA Assays for measuring steroids

Jul 30 2016

DRG International, a leading international medical diagnostic company, will showcase the Newly Optimized DRG® Saliva ELISA Assays at the 2016 AACC in Philadelphia, Pennsylvania from August 02-04. DRG® Optimized Saliva ELISA Assays are easy-to-use, non-invasive sampling test kits designed for the measurement of the free (unbound) fraction of steroids. These tests allow for simple, patient-friendly measurement of hormone profiles. They are also a reliable measurement of steroids in veterinary saliva samples without further pre-treatment.

DRG® Optimized Saliva ELISAS include:
•DHEA
•Cortisol
•Estradiol
•Testosterone
•Progesterone

Clear Advantages:
•FDA CLEARED TESTS
•Increased stability and linearity
•Ready to use reagents and user friendly assays
•Non-invasive, easy sampling particularly for babies and children
•Higher diagnostic relevance with reproducible and reliable results compared to serum analytics
•EXCELLENT CORRELATION TO MASS SPECTROMETRY

DRG® International, Inc., is committed to providing the medical and research community with cutting edge, easy-to-use and effective diagnostic equipment. DRG® International is constantly looking towards the future in order to continue to produce and distribute the highest-quality products.

DRG International will be showcasing at the AACC in Booth 3713. Press inquiries are welcome. For more information, please contact Michael Martini (Sales & Marketing Director for DRG International) at (973) 564-7555.